Biocytics

Biocytics The Applications of Living Cells. Biotech comoany incubated within Carolina BioOncology Institute. https://www.facebook.com/share/1AvKAi3VJg/?mibextid=wwXIfr

Our mission is to research and develop novel cellular therapies.

Big thank you to the students from Davidson College for visiting! We loved sharing our work, our mission, and the exciti...
11/15/2025

Big thank you to the students from Davidson College for visiting! We loved sharing our work, our mission, and the exciting career paths ahead in biotech and in immuno-oncology cancer research.


Today we welcomed  to BioCytics Inc for an exciting presentation on Revolutionizing Immune Cell Therapy with Functional ...
11/12/2025

Today we welcomed to BioCytics Inc for an exciting presentation on Revolutionizing Immune Cell Therapy with Functional Single Cell Analysis.

We continue to explore advanced technologies that accelerate discovery and deepen our understanding of immune cell function to strengthen our cell therapy development pipeline.

We are proud to celebrate Dr. Gaby Lizana-Vasquez, BioCytics HAL Research Scientist, for being selected as a 2025 Intern...
11/07/2025

We are proud to celebrate Dr. Gaby Lizana-Vasquez, BioCytics HAL Research Scientist, for being selected as a 2025 International Society for Cell & Gene Therapy Cell Therapy Leadership Training Program Scholar. 🧬

This recognition reflects our mission at BioCytics to advance cell therapies through innovation, collaboration, and scientific excellence.

We are honored to see Dr. Lizana-Vasquez representing our team among the next generation of leaders shaping the future of cellular medicine. 🌍

Biocytics and Carolina BioOncology Institute are proud to sponsor the Biomedical Sciences Symposium hosted by UNC Charlo...
09/15/2025

Biocytics and Carolina BioOncology Institute are proud to sponsor the Biomedical Sciences Symposium hosted by UNC Charlotte’s Center for Biomedical Engineering and Science in collaboration with the North Carolina Biotechnology Center.

This event unites breakthrough discoveries, translational research, and new collaborations in biomedical sciences. We are honored to support a forum that further advances science, fosters partnerships, and shapes the future of biomedical research!🔬

09/07/2025

✨ Congratulations to Dr. John Powderly and the entire team at Carolina BioOncology Institute on 20 years of advancing cancer care and research! ✨

Founded by Dr. John Powderly in 2005, CBOI began with a vision to provide patients with access to the latest Phase I immuno-oncology clinical trials. From humble beginnings of decision making around a kitchen table, the institute has grown into a nationally recognized center offering cutting-edge treatments for late-stage cancer patients.

Over the past two decades, CBOI has opened more than 150 early-phase immunotherapy trials and has become a beacon of hope for patients seeking innovative treatment options.

Here's to 20 years of dedication, innovation, and compassionate care and to many more! 👏💙

🔬 Celebrating 20 years of innovation at BioCytics!BioCytics began in 2005 as a true partnership between Dr. John Powderl...
09/06/2025

🔬 Celebrating 20 years of innovation at BioCytics!

BioCytics began in 2005 as a true partnership between Dr. John Powderly and his brother Jim Powderly. Around their kitchen table that summer, they mapped out the vision for what would become a pioneering biotechnology company dedicated to individualized cell therapies, including development of an autologous adaptive immune cell therapy.

Based in Huntersville, North Carolina, BioCytics focuses on developing personalized cancer immunotherapies and continues to push the boundaries of pre-clinical research with the goal of transforming cancer treatment and offering hope to patients worldwide.

Here’s to two decades of collaboration, innovation, and vision, and many more to come! 🌟

Big moves at Biocytics! ✨We’re thrilled to welcome Stephanie, William, Roberto, and Cheyenne, four amazing new team memb...
07/25/2025

Big moves at Biocytics! ✨We’re thrilled to welcome Stephanie, William, Roberto, and Cheyenne, four amazing new team members joining us from leading biotech and life sciences companies. They bring serious experience in operations, quality, and GMP to help us grow our biobank and manufacturing space the right way.
The future is bright and we’re just getting started. 🚀🔬

Carolina BioOncology Institute and Biocytics have successfully deployed the first live openEHR development framework in ...
07/18/2025

Carolina BioOncology Institute and Biocytics have successfully deployed the first live openEHR development framework in a US clinical setting. Announced today during the openEHR International Affiliate Program board meeting, this milestone lays the foundation for structured, interoperable, and regulatory-ready clinical data management.

The initial phase includes the deployment of the core framework and clinical datastore. đź”®Future phases will migrate the structured medical record data into the openEHR environment. The goal is to build a modern, scalable clinical infrastructure that empowers our clinical teams and research partners. Our focus is to accelerate the "citizen centric" democratization of clinical data while maintaining the highest standards of data integrity.

Find us on the global map at openEHR and reach out about new affiliate membership groups openEHR US & Global Life Science. Any questions, contact us directly for more information.

We're thrilled to be supporting a cutting-edge research project led by Dr. Susan Trammell at UNC Charlotte, recently fun...
06/17/2025

We're thrilled to be supporting a cutting-edge research project led by Dr. Susan Trammell at UNC Charlotte, recently funded by NCInnovation!

In May, BioCytics joined as a sub-awardee to assist in the project’s evaluation of Light-Assisted Drying (LAD), a novel laser technology designed to enable ambient storage of vaccines and other therapeutics, potentially cutting refrigeration costs by up to 80%.

We’re honored to contribute to this impactful work that could help transform biologics storage and distribution.

đź”— Read more about the full award here: https://inside.charlotte.edu/2025/05/16/pinku-mukherjee-susan-trammell-awarded-ncinnovation-research-grants/ and about the other awardees here:
https://ncinnovation.org/media/ncinnovation-approves-13-6-million-to-support-17-university-rd-projects/

🔬 Let us re-introduce ourselves — Welcome to BioCytics! We’re a cell therapy company driven by one mission: to create pe...
05/29/2025

🔬 Let us re-introduce ourselves — Welcome to BioCytics!

We’re a cell therapy company driven by one mission: to create personalized, autologous immune therapies for cancer patients using their body’s own adaptive immune response. At BioCytics, we believe the future of immunotherapy is already inside you.

Unlike traditional therapies, our AACT (Autologous Adaptive Cell Therapy) platform identifies and amplifies your body’s best immune cells—those already reacting to your tumor. Then we reinfuse them to help your immune system fight harder and smarter.

Follow us to learn more about our science, our team, and our mission.

🔬🎉 As Lab Week comes to a close, we’re reflecting on the dedication, collaboration, and innovation that power everything...
04/25/2025

🔬🎉 As Lab Week comes to a close, we’re reflecting on the dedication, collaboration, and innovation that power everything we do at Biocytics. From breakthrough discoveries to daily wins behind the scenes, our lab team is the heart of it all.

Thank you to our incredible staff for your tireless commitment to science, precision, and progress. Every data point, every test, every challenge met—it all adds up to something bigger, and we're proud to do it together.

Here’s to continued excellence, curiosity, and impact. 💪✨

At BioCytics, our goal is to help cancer patients fight back—using their own immune systems. Our name means “the applica...
04/05/2025

At BioCytics, our goal is to help cancer patients fight back—using their own immune systems. Our name means “the application of living cells,” and that’s exactly what we’re doing. With our Autologous Adaptive Cell Therapy (AACT), we are working towards creating a personalized treatment by collecting your immune cells and a sample of your tumor. Then, in our lab, we figure out which of your immune cells are already trying to fight the cancer—and we give those cells a powerful boost.

Unlike other treatments like CAR-T, which change your cells through genetic engineering, our method works with your body’s natural response. We don’t need to reprogram your cells—we simply find the best ones and multiply them, so your immune system has the strength to fight your tumor more effectively.

Here’s why this approach is different:
• It uses your cells and nothing is genetically altered
• It’s made just for your tumor
• It’s safer, with fewer risks of intense side effects
• It can be made faster and more affordably
• You can receive repeat doses if the cancer returns or changes

We believe in making cutting-edge cancer treatments more natural, more personal, and more accessible. Because no two patients are the same—your therapy shouldn’t be either.

Address

9801 Kincey Avenue, Suite 145
Huntersville, NC
28078

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 12pm

Alerts

Be the first to know and let us send you an email when Biocytics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biocytics:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram